Chemisty and Biological Activity
Chemical Formula
C2306H3594N610O694S26
Chemical Name
Human LFA-3/IgG1 fusion protein
Chemical Structure
CFSQQIYGVVYGNVTFHVPSNVPLKEVLWKKQKDKVAELENSEFRAFSSF
KNRVYLDTVSGSLTIYNLTSSDEDEYEMESPNITDTMKFFLYVLESLPSP
TLTCALTNGSIEVQCMIPEHYNSHRGLIMYSWDCPMEQCKRNSTSIYFKM
ENDLPQKIQCTLSNPLFNTTSSIILTTCIPSSGHSRHRYALIPIPLAVIT
TCIVLYMNGILKCDRKPDRTNSNRVEPKSCDKTHTCPPCPAPELLGGPSV
FLFPPKPKDTLMISRTPEVTCVVVDVSHEDPQVKFNWYVDGVQVHNAKTK
PREQQYNSTYRVVSVLTVLHQNWLDGKEYKCKVSNKALPAPIEKTISKAK
GQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENN
YKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKS
LSLSPGK
Molecular Weight
51801.1
Physical State
Liquid
Melting Point
Not Available
Water Solubility
Not Available
Isoelectric Point
7.86
Organisms Affected
Humans and other mammals
Phase 1 Metabolising Enzyme (1-st Step of Metabolism)
Not Available
Primary Drug Target
Name | CD2 lymphocyte antigen | Gene Name | CD2 | Synonyms | T-cell surface antigen CD2 precursor; T-cell surface antigen T11/Leu- 5; LFA-2; LFA-3 receptor; Erythrocyte receptor; Rosette receptor | Specific Function | CD2 interacts with lymphocyte function-associated antigen (LFA-3) and CD48/BCM1 to mediate adhesion between T cells and other cell types. CD2 is implicated in the triggerring of T- cells, the cytoplasmic domain is implicated in the signaling function |
|